Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Troppan, K; Hofer, S; Wenzl, K; Lassnig, M; Pursche, B; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Deutsch, A; Neumeister, P.
Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
PLoS One. 2015; 10(4):e0123922-e0123922
Doi: 10.1371/journal.pone.0123922
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Deutsch Alexander
-
Hofer Sybille
-
Prochazka Katharina
- Co-Autor*innen der Med Uni Graz
-
Beham-Schmid Christine
-
Neumeister Peter
-
Renner Wilfried
-
Steinbauer Elisabeth
-
Wenzl Kerstin
-
Wiltgen Marco
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Multiple myeloma (MM) is a malignant clonal expansion of plasma cells in the bone marrow and belongs to the mature B-cell neoplams. The pathogenesis of MM is associated with constitutive NF-κB activation. However, genetic alterations causing constitutive NF-κB activation are still incompletely understood. Since A20 (TNFAIP3) is a suppressor of the NF-κB pathway and is frequently inactivated in various lymphoid malignancies, we investigated the genetic and epigenetic properties of A20 in MM. In total, of 46 patient specimens analyzed, 3 single base pair exchanges, 2 synonymous mutations and one missense mutation were detected by direct sequencing. Gene copy number analysis revealed a reduced A20 gene copy number in 8 of 45 (17.7%) patients. Furthermore, immunohistochemical staining confirmed that A20 expression correlates with the reduction of A20 gene copy number. These data suggest that A20 contributes to tumor formation in a significant fraction of myeloma patients.
- Find related publications in this database (using NLM MeSH Indexing)
-
Apoptosis - genetics
-
Carcinogenesis - genetics
-
DNA-Binding Proteins - biosynthesis
-
Gene Dosage - genetics
-
Gene Expression Regulation, Neoplastic -
-
Humans -
-
Intracellular Signaling Peptides and Proteins - biosynthesis
-
Multiple Myeloma - genetics
-
Mutation, Missense -
-
NF-kappa B - genetics
-
Nuclear Proteins - biosynthesis
-
Tumor Suppressor Proteins - biosynthesis